ArticleJournal of clinical laboratory analysis2022

MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3.

Li-Zhe Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.